Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomobie is a biotechnology company specializing in bio-electromagnetic therapy and regenerative medicine. The company develops non-invasive medical devices based on its proprietary Magnetic Induced Energy (MIE) technology, which aims to stimulate cellular repair and improve microcirculation. Their product portfolio includes the Biomobie Heart and other wearable or stationary devices targeting chronic conditions such as cardiovascular disease, insomnia, and metabolic disorders. Biomobie operates globally with a significant presence in China and the United States, focusing on integrating digital health with bio-electronic treatments. The company's approach centers on the use of specific electromagnetic frequencies to influence biological processes at the cellular level. Their technology is currently utilized in various clinical settings for rehabilitation and chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomobie.